Literature DB >> 15331534

Involvement of hypothalamic histamine H1 receptor in the regulation of feeding rhythm and obesity.

Takayuki Masaki1, Seiichi Chiba, Tohru Yasuda, Hitoshi Noguchi, Tetsuya Kakuma, Takeshi Watanabe, Toshiie Sakata, Hironobu Yoshimatsu.   

Abstract

Histamine H(1) receptors (H(1)-Rs) are found in peripheral tissues and in regions of the hypothalamus that are concerned with regulating body composition. In the present study, we investigated the detailed mechanisms of histamine H(1)-Rs in the development of obesity. Histamine H(1)-R knockout (H1KO) mice gradually developed mature-onset obesity, which was accompanied by hyperphagia and decreased expression of uncoupling protein-1 (UCP-1) mRNA. Both younger nonobese (12-week-old) and older obese (48-week-old) H1KO mice exhibited impairment of the responsiveness to the leptin. In addition, disruption of the diurnal rhythm of feeding occurred before the onset of obesity in H1KO mice. Correction of these abnormal feeding rhythms by means of scheduled feeding caused a reduction in obesity and associated metabolic disorders in H1KO mice. Furthermore, central administration of a histamine H(1)-R agonist affected feeding behavior, body weight, and c-fos-like immunoreactivity in the hypothalamus. Taken together, these findings suggest that histamine H(1)-Rs are crucial for the regulation of feeding rhythm and in mediating the effects of leptin. Early disruption of H(1)-R-mediated functions in H1KO mice may lead to hyperphagia and decreased expression of UCP-1 mRNA, which may contribute to the development of obesity in these animals. In addition, centrally acting histamine H(1)-R may be a novel therapeutic target for the treatment of obesity and related metabolic disorders.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15331534     DOI: 10.2337/diabetes.53.9.2250

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  68 in total

1.  Effects of fasting on hypoxic ventilatory responses and the contribution of histamine H1 receptors in mice.

Authors:  Yasuyoshi Ohshima; Michiko Iwase; Masahiko Izumizaki; Hideaki Nakayama; Ichiei Narita; Ikuo Homma
Journal:  J Physiol Sci       Date:  2010-12-25       Impact factor: 2.781

Review 2.  Antipsychotic drugs and obesity.

Authors:  Christoph U Correll; Todd Lencz; Anil K Malhotra
Journal:  Trends Mol Med       Date:  2010-12-22       Impact factor: 11.951

3.  Chronic administration of olanzapine induces metabolic and food intake alterations: a mouse model of the atypical antipsychotic-associated adverse effects.

Authors:  R Coccurello; A Caprioli; O Ghirardi; R Conti; B Ciani; S Daniele; A Bartolomucci; A Moles
Journal:  Psychopharmacology (Berl)       Date:  2006-05-13       Impact factor: 4.530

4.  Dipsogenic potentiation by sodium chloride but not by sucrose or polyethylene glycol in tuberomammillary-mediated polydipsia.

Authors:  J Mahía; A Bernal; A Puerto
Journal:  Exp Brain Res       Date:  2007-07-14       Impact factor: 1.972

Review 5.  Brain regulation of energy balance and body weight.

Authors:  Liangyou Rui
Journal:  Rev Endocr Metab Disord       Date:  2013-12       Impact factor: 6.514

6.  The relation of atypical antipsychotic use and stress with weight in individuals at clinical high risk for psychosis.

Authors:  Joya N Hampton; Hanan D Trotman; Jean Addington; Carrie E Bearden; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Daniel H Mathalon; Thomas H McGlashan; Ming T Tsuang; Diana O Perkins; Larry J Seidman; Scott W Woods; Elaine F Walker
Journal:  Stress Health       Date:  2018-06-28       Impact factor: 3.519

Review 7.  Development of criteria for a diagnosis: lessons from the night eating syndrome.

Authors:  Albert J Stunkard; Kelly C Allison; Allan Geliebter; Jennifer D Lundgren; Marci E Gluck; John P O'Reardon
Journal:  Compr Psychiatry       Date:  2008-11-26       Impact factor: 3.735

Review 8.  Circadian rhythms, sleep, and metabolism.

Authors:  Wenyu Huang; Kathryn Moynihan Ramsey; Biliana Marcheva; Joseph Bass
Journal:  J Clin Invest       Date:  2011-06-01       Impact factor: 14.808

9.  Adiposopathy: treating pathogenic adipose tissue to reduce cardiovascular disease risk.

Authors:  Harold Bays; Helena W Rodbard; Alan Bruce Schorr; J Michael González-Campoy
Journal:  Curr Treat Options Cardiovasc Med       Date:  2007-08

10.  Thyrotropin-releasing hormone-containing axons innervate histaminergic neurons in the tuberomammillary nucleus.

Authors:  Anna Sárvári; Erzsébet Farkas; Andrea Kádár; Györgyi Zséli; Tamás Füzesi; Ronald M Lechan; Csaba Fekete
Journal:  Brain Res       Date:  2012-10-11       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.